Clinical Trial Update: Phase I Trial of Sorafenib + FOLFIRI In Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase I trial evaluating sorafenib in combination with FOLFIRI for metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED